Medical Device News Magazine

Jennifer Esposito Appointed to VivaLNK Board of Directors: Over 20 Years of Experience, Esposito Will Advise the Executive Team and Assist in Growth in the Digital Health Space

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

December 1, 2020

Jennifer Esposito joins the VivaLNK its Board of Directors.

Jennifer Esposito experience lies in the healthcare technology and medical device fields and will provide VivaLNK and its executive team a valuable resource to help direct the company’s strategic growth as it powers the world’s leading RPM (remote patient monitoring) technologies.

Esposito is an executive with over 20 years of experience in the global healthcare IT, medical device, biotechnology, and the health and life sciences industry, currently serving as the VP, Health at Magic Leap. She is currently leading Magic Leap’s Health business unit. Prior to joining Magic Leap, she held leadership roles at GE Healthcare and was more recently the General Manager of Health and Life Sciences at Intel Corporation.

In addition, Esposito has worked in academic medicine and clinical research. In her many years of experience, she has led business development, commercial and service operations, as well as both upstream and downstream strategy and marketing. Her expertise lies in driving business growth and strategies by enabling the adoption of emerging technologies in the healthcare industry.

“I believe we are on the cusp of an acceleration in the transformation of healthcare that we’ve never seen before that will improve health, quality of life, safety and security worldwide,” said Esposito. “Working alongside the incredible executive team at VivaLNK allows my passion for healthcare technology to be fully leveraged. I am honored to have a part in the strategy and continued growth of this innovative company.”

The VivaLNK platform has enabled over 90 healthcare solution partners in 22 countries worldwide, and includes applications for remote and clinical patient monitoring for mobile cardiac telemetry, pharmaceutical clinical trials, and COVID patient monitoring to name a few.

“In order for remote monitoring and telemedicine to reach its full potential, solution providers and clinical or research entities need to be able to depend on the capture and transmission of data, as well as seamlessly implement RPM into existing and new infrastructure. Jennifer not only has deep understanding of this space, but also knows the challenges of our partners well, and I’m thrilled to have her assistance in delivering the highest-quality, turnkey service on the market that ultimately changes the status and adoption of RPM today,” said Jiang Li, CEO of VivaLNK.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”